WeVote

Bill

Bill

HB 1347

Cancer Treatment and Research

2025 Regular Session Introduced by Taylor Yarkosky

Florida cancer treatment and research bill died in subcommittee; companion Senate bill SB 2514 passed and was enacted into law.

Died in Health Professions & Programs Subcommittee, companion bill(s) passed, see SB 2514 (Ch. 2025-204)
0
WeVote Research Nonpartisan
Bill Summary · HB 1347

Legislative bill overview

HB 1347 was a Florida bill introduced by Representative Taylor Yarkosky focused on cancer treatment and research initiatives. The bill died in the Health Professions & Programs Subcommittee in June 2025, though a companion bill (SB 2514) passed and was enacted into law (Ch. 2025-204).

Why is this important

Cancer treatment and research policy directly affects healthcare access, pharmaceutical development, and public health outcomes for Florida residents. The passage of the companion Senate bill indicates that cancer-related policy priorities were ultimately advanced through the legislative process, even though this House version did not survive.

Potential points of contention

  • Specifics unknown: Without access to the bill's actual text, the particular policy mechanisms—whether involving funding, licensing, treatment protocols, or research incentives—cannot be evaluated for controversy
  • Companion bill differences: HB 1347's failure alongside SB 2514's passage suggests substantive differences that made one version preferable to legislators
  • Resource allocation: Cancer treatment and research bills typically involve budget questions about public versus private funding and priority-setting among health conditions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.